Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1127658

A strategy towards the generation of testable adverse outcome pathways for nanomaterials


Murugadoss, Sivakumar; Vinković Vrček, Ivana; Pem, Barbara; Jagiello, Karolina; Judzinska, Beata; Sosnowska, Anita; Martens, Marvin; Willighagen, Egon L.; Puzyn, Tomasz; Dusinska, Maria et al.
A strategy towards the generation of testable adverse outcome pathways for nanomaterials // ALTEX-Alternatives to Animal Experimentation, 38 (2021), 4; 580-594 doi:10.14573/altex.2102191 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1127658 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
A strategy towards the generation of testable adverse outcome pathways for nanomaterials

Autori
Murugadoss, Sivakumar ; Vinković Vrček, Ivana ; Pem, Barbara ; Jagiello, Karolina ; Judzinska, Beata ; Sosnowska, Anita ; Martens, Marvin ; Willighagen, Egon L. ; Puzyn, Tomasz ; Dusinska, Maria ; Cimpan, Mihaela Roxana ; Fessard, Valerie ; Hoet, Peter H.

Izvornik
ALTEX-Alternatives to Animal Experimentation (1868-596X) 38 (2021), 4; 580-594

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
nanosafety, alternative animal free-testing, adverse outcome pathways (AOP), in vitro toxicity assay, AOP-anchored predictive models

Sažetak
Manufactured nanomaterials (NMs) are increasingly used in a wide range of industrial applications leading to a constant increase in the market size of nano-enabled products. The increased production and use of NMs are constantly raising concerns among different stakeholder groups with regard to their effects on human and environmental health. Currently, nanosafety hazard assessment is still widely performed using in vivo (animal) models, however the development of robust and regulatory relevant strategies is required to prioritize and/or reduce animal testing. Adverse outcome pathways (AOPs) are a structured representation of biological events that start from a molecular initiating event (MIE) leading to an adverse outcome (AO) through a series of key events (KEs). The AOP framework offers great advancement to risk assessment and regulatory safety assessments. While AOPs for chemicals have been more frequently reported, AOPs collection for NMs is narrow. By using existing AOPs, we aimed to generate simple and testable strategies to predict if a given NM has the potential to induce a MIE leading to an AO through a series of KEs. Firstly, we identified potential MIEs or initial KEs reported for NMs in the literature. Then, we searched the identified MIE or initial KEs as keywords in the AOP-Wiki to find associated AOPs. Finally, using two case studies, we demonstrated here how in vitro strategies can be used for testing the identified MIE/KEs.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Interdisciplinarne prirodne znanosti, Farmacija



POVEZANOST RADA


Projekti:
EK-H2020-814425 - Znanstveno utemeljeno upravljanje rizikom nano-tehnologije (RiskGONE) (Vinković Vrček, Ivana, EK ) ( CroRIS)

Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb

Profili:

Avatar Url Barbara Pem (autor)

Avatar Url Ivana Vinković Vrček (autor)

Poveznice na cjeloviti tekst rada:

doi www.altex.org pubmed.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Murugadoss, Sivakumar; Vinković Vrček, Ivana; Pem, Barbara; Jagiello, Karolina; Judzinska, Beata; Sosnowska, Anita; Martens, Marvin; Willighagen, Egon L.; Puzyn, Tomasz; Dusinska, Maria et al.
A strategy towards the generation of testable adverse outcome pathways for nanomaterials // ALTEX-Alternatives to Animal Experimentation, 38 (2021), 4; 580-594 doi:10.14573/altex.2102191 (međunarodna recenzija, članak, znanstveni)
Murugadoss, S., Vinković Vrček, I., Pem, B., Jagiello, K., Judzinska, B., Sosnowska, A., Martens, M., Willighagen, E., Puzyn, T. & Dusinska, M. (2021) A strategy towards the generation of testable adverse outcome pathways for nanomaterials. ALTEX-Alternatives to Animal Experimentation, 38 (4), 580-594 doi:10.14573/altex.2102191.
@article{article, author = {Murugadoss, Sivakumar and Vinkovi\'{c} Vr\v{c}ek, Ivana and Pem, Barbara and Jagiello, Karolina and Judzinska, Beata and Sosnowska, Anita and Martens, Marvin and Willighagen, Egon L. and Puzyn, Tomasz and Dusinska, Maria and Cimpan, Mihaela Roxana and Fessard, Valerie and Hoet, Peter H.}, year = {2021}, pages = {580-594}, DOI = {10.14573/altex.2102191}, keywords = {nanosafety, alternative animal free-testing, adverse outcome pathways (AOP), in vitro toxicity assay, AOP-anchored predictive models}, journal = {ALTEX-Alternatives to Animal Experimentation}, doi = {10.14573/altex.2102191}, volume = {38}, number = {4}, issn = {1868-596X}, title = {A strategy towards the generation of testable adverse outcome pathways for nanomaterials}, keyword = {nanosafety, alternative animal free-testing, adverse outcome pathways (AOP), in vitro toxicity assay, AOP-anchored predictive models} }
@article{article, author = {Murugadoss, Sivakumar and Vinkovi\'{c} Vr\v{c}ek, Ivana and Pem, Barbara and Jagiello, Karolina and Judzinska, Beata and Sosnowska, Anita and Martens, Marvin and Willighagen, Egon L. and Puzyn, Tomasz and Dusinska, Maria and Cimpan, Mihaela Roxana and Fessard, Valerie and Hoet, Peter H.}, year = {2021}, pages = {580-594}, DOI = {10.14573/altex.2102191}, keywords = {nanosafety, alternative animal free-testing, adverse outcome pathways (AOP), in vitro toxicity assay, AOP-anchored predictive models}, journal = {ALTEX-Alternatives to Animal Experimentation}, doi = {10.14573/altex.2102191}, volume = {38}, number = {4}, issn = {1868-596X}, title = {A strategy towards the generation of testable adverse outcome pathways for nanomaterials}, keyword = {nanosafety, alternative animal free-testing, adverse outcome pathways (AOP), in vitro toxicity assay, AOP-anchored predictive models} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font